Rheumatology

Your Article Summary

See Latest Articles

Targeting lymphocyte activation to treat rheumatoid arthritis
Joint, Bone, Spine, 06/25/09

Falgarone G et al. - In RA patients, abatacept is effective in decreasing the arthritis, pain, disability, fatigue, and radiological joint damage. Abatacept provides lasting remissions or low levels of disease activity and therefore constitutes a valuable addition to the current therapeutic armamentarium for RA, which is hoped to make a full remission an attainable goal in the overall population of RA patients.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09

See All of Clinical Pharmacology

Today in Rheumatoid Arthritis...keeping you current

Receive free subspecialty "5-minute updates" via email

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09

Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years drug survival
Rheumatology International, 10/14/09

See All of Rheumatoid Arthritis